In vitro antitumor activity of Gracilaria corticata (a red

alga) against Jurkat and molt-4 human cancer cell lines by Zandi, Keivan et al.
African Journal of Biotechnology Vol. 9(40), pp. 6787-6790, 4 October, 2010     
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB10.602 
ISSN 1684–5315 © 2010 Academic Journals  
 
 
 
Full Length Research Paper 
 
In vitro antitumor activity of Gracilaria corticata (a red 
alga) against Jurkat and molt-4 human cancer cell lines 
 
Keivan Zandi1,2*, Saeed Tajbakhsh1,2, Iraj Nabipour1,2, Zahra Rastian1, Forough Yousefi1, 
Samin Sharafian1 and Kohzad Sartavi3 
 
1The Persian Gulf Marine Biotechnology Research Center, Bushehr University of Medical Sciences, Bushehr, Iran. 
2The Persian Gulf Tropical and Infectious Disease Research Center, Bushehr University of Medical Sciences, Bushehr, 
Iran. 
3Jahad- Keshavarzi Research Center, Bushehr, Iran. 
 
Accepted 9 July, 2010 
 
Gracilaria corticata is a red alga which can be collected from many sea coasts around the world such as 
China, India, Persian Gulf, etc. The Persian Gulf is a unique marine habitat infested with diverse 
seaweeds. The aim of the present study is to explore anticancer potential of the crude extracts from G. 
corticata which was collected from the Bushehr coast (South west of Iran). Here, different concentration 
of the aqueous extract from G. corticata was tested for probable antitumoral activity on Jurkat and molt-
4 human lymphoblastic leukemic cell lines. The cells were treated by different concentration of algal 
extract and the number of viable cells was determined by trypan blue. Also, cytotoxicity of the extract 
was evaluated by methyl thiazolyl tetrazolium (MTT) assay. The results showed that 9.336 and 9.726 
µg/µl of algal extract were the most effective concentrations against Jurkat and molt-4 cells, 
respectively. The water crude extract of red alga G. corticata had significant anticancer activity and it 
might be a good candidate for further investigations in order to develop a natural compound as an 
anticancer agent which can be used for the production of potential anticancer drug and novel 
pharmaceutical leads.  
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INTRODUCTION 
 
Cancer is one of the most serious threats to human 
health in the world and chemotherapy is still the standard 
treatment method. Most of the anticancer drugs currently 
used in chemotherapy are cytotoxic to normal cells and 
cause immunotoxicity which affects not only tumor 
development, but also aggravates patient’s recovery. The 
discovery and identification of new antitumor drug with 
low side effects on immune system has become an 
essential goal in many studies of immunopharmacology 
(Xu et al., 2009). With this aim, many attentions have 
been paid to natural compounds in plants, marine organism 
and microorganisms. Regarding the low side effects of 
plants   and   other   natural    compounds,   scientists are   
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interested in working on them to find new medications. 
Finding anticancer agents from plant sources started in 
the earliest 1950s with the discovery and development of 
vinca alkaloids, vinblastine and vincristine and the isolation 
of the cytotoxic podophyllotoxins (Cragg and Newman, 
2005).  
In one study, antitumor activity of teriterpenoid fractions 
from the rhizomes of Astilbe chinensis in tumor bearing 
mouse was evaluated (Tu et al., 2008). It significantly 
inhibited the growth of mice transplantable tumor and 
remarkably increased splenocytes proliferation, natural 
killer cells activity and the level of interleukin-2 secreted 
by splenocytes in tumor-bearing mice.  
Marine algae are one of the natural resources in the 
marine ecosystem. They contain various biologically active 
compounds which have been used as source of food, 
feed and medicine. Until now, more than 2400 marine 
natural products have been isolated from seaweeds of 
subtropical and tropical populations (Manilal et al., 2009). 
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Recent findings evidenced that seaweeds contained 
antiviral (Matsuhiro et al., 2005), antibacterial (Xu et al., 
2003), antifungal (Li et al., 2006) and antitumoral (Harada 
et al., 1997; Kezia et al., 2008) potentials, among numerous 
others. 
The epidemiological data are supported by rodent model 
studies demonstrating protective effects of dietary kelps 
and other red and green algae against mammary, intestinal 
and skin carcinogenesis (Yuan and Walsh, 2006). 
Many studies have focused on water soluble antitumor 
active substances from various marine algae, however 
most anticancer agent have not been used clinically 
because of their undesirable side effects on normal cells 
(Harada et al., 1997). According to existing literature, 
more than ten new experimental anti-tumor agents 
derived from marine sources have entered clinical trials, 
including bryostatin-1, aplidine, ecteinascidin-743 (ET-
743), Kahalalide F, as well as derivatives of dolastatin 
such as TZT-1027 and LU 103793 (Song et al., 2008). 
Here, we tested the in vitro antitumor activity of Gracilaria 
corticata a red alga which is found in many part of the 
world such as China, Indian Ocean, Persian Gulf, etc. We 
have tested the algal water extracts activity against 
Jourkat and molt-4 cells which are two kinds of human 
leukemic cell lines.  
 
 
MATERIALS AND METHODS 
  
Preparation of algal extract 
 
G. coticata, a red alga, was collected along the Bushehr coast of 
Persian Gulf during September, 2008. The alga was rinsed with 
distilled water. About 10 g of fresh alga which was equal to 1 g of 
dried one was homogenized in 100 ml cold double distilled water 
completely. Clarification of the algal mixture was carried out by 
filtration method using Whatman paper No.1 filter paper. Finally, 
algal clarified crude extract was sterilized by millipore filter with 0.22 
µm pore size and stored at -80°C until the date of use.  
 
 
Cell lines  
 
Human Jurkat (lymphoblast-like) and molt-4 (lymphoblast-like) cell 
lines were chosen as proper representatives of human leukemic 
cell lines which we have received as gift from Tarbiat Modarres 
University.  
 
 
Cell culture  
  
The cells were cultured in 50 ml cell culture flasks (Orange Scientific) 
or 96 wells cell culture microplates (Orange Scientific) by using 
RPMI 1640 (Gibco) containing 10% fetal bovine serum (Gibco) and 
were incubated at 37°C in the presence of 5% CO2 (Morgan et al., 
1992). 
 
 
Trypan blue exclusion test 
 
In the first step to determine the viable cell number before and after 
treatment by algal extract, trypan blue exclusion test was used as a 
semi quantitative method. Briefly, the cancer cells were seeded at a  
 
 
 
 
density of 2 × 104 cells/well and they were treated with different 
concentrations of the algal extract for 72 h at 37°C in the presence 
of 5% CO2. After 72 h, 20 µl of medium and equal volume of trypan 
blue were mixed and viable and dead cells were counted by 
Neubauer haemacytometer (Morgan et al., 1992). 
 
 
Methyl thiazolyl tetrazolium (MTT) assay test 
 
To determine the cytotoxicity of algal extract against studied cancer 
cell lines, MTT assay test was used as a quantitative and approved 
method. In this method, 10 µl of MTT stock solution (5 mg/ml in 
PBS) was added to 90 µl medium of wells which were treated by 
different concentrations of algal extract for 72 h. The microplate 
was incubated at 37°C for 4 h and then, the optical density of each 
well was read by microplate reader (ASYS – EXPERT 96) at 540 
nm (Van de Loosdrecht et al., 1994). 
 
 
RESULTS 
 
Anticancer activity of G. corticata against Jurkat cell 
line  
 
The viability test monitored by trypan blue exclusion test 
in order to determine the algal extract activity against 
Jurkat cells is presented in Table 1. Based on these data, 
it was demonstrated that Jurkat cells of negative control 
wells (without extract) were increased from 2 × 104 to 7 × 
104 after 72 h. As shown in Table 1, in concentrations 
above 8.167 µg/µl of algal extract, the viable cells were 
decreased which demonstrated the cytostatic activity of 
the algal extract on Jurkat cells. The most effective 
concentration in which the number of viable cells was 
decreased signifantly was 9.336 µg/µl of algal extract. 
Dead cells were identified in all microplate wells. The 
highest number of dead cells has been shown for the well 
whose cells were treated by 9.726 µg/µl of algal extract. 
Dead cell increase in negative control wells (without 
extract) was almost equal to the wells which were treated 
by 5.835 µg/µl concentration of extract.  
Results about cytotoxicity of the algal extract against 
Jurkat cell line through MTT assay is shown in Table 3. 
Based on data obtained, it was concluded that 9.336 µg/ 
µl of G. corticata extract showed potent cytostatic effect 
which was confirmed by result of counted viable cells. 
 
 
Anticancer activity of G. corticata against molt-4 cell 
line  
 
Results of the trypan blue exclusion tests over viable and 
dead cell counting after exposure to different concentration 
of extract against molt-4 cells is summarized in Table 2. 
As shown in Table 1, the number of negative control 
(without extract) molt-4 cells were increased from 2 × 104 
to 6.8 × 104 after 72 h. There was a suppression effect on 
cell replication for the concentration 8.167 µg/µl, which 
could not be expressed as a consistent anticancer activity. 
The most effective concentration of algal  extract  against  
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Table 1. Result of trypan blue exclusion test on Jurkat cell line in 72 h post treatment with G. 
corticata extract. 
 
Number of dead cells Number of viable cells Extract concentration (µg/µl) 
6×103 7×104 0 
4×103 5.8×104 2.723 
5×103 5.6×104 4.668 
4×103 3.8×104 5.057 
6×103 3.6×10 5.835 
4×103 3×104 6.224 
5.5×103 3×104 7.391 
6×103 2.2×104 8.167 
4×103 2×104 8.947 
8×103 1.8×104 9.336 
8.2×103 1.8×104 9.726 
 
 
 
Table 2. Result of trypan blue exclusion test on molt-4 cell line in 72 h post treatment with G. 
corticata extract. 
 
Number of dead cells Number of viable cells Extract concentration (µg/µl) 
3×103 6.8×104 0 
3×103 5.1×104 2.723 
3×103 4.8×104 4.668 
4×103 4.78×104 5.057 
4×103 4.5×104 5.835 
3.8×103 4×104 6.224 
4.3×103 3.7×104 7.391 
4.2×103 3×104 8.167 
4.2×103 2.5×104 8.947 
4×103 2.2×105 9.336 
4.2×103 1.9×104 9.726 
 
 
 
molt-4 cells replication was 9.726µg/µl. The number of 
dead cells in test microplate wells showed that the algal 
extract did not exhibit considerable cytotoxicity. As shown 
in Table 3, the result of MTT assay confirmed that the 
most effective concentration against molt-4 cells was 
9.726µg/µl.  
 
 
DISCUSSION 
 
Up till now, more than 2400 marine natural products have 
been isolated from seaweeds of subtropical and tropical 
populations (Manilal et al., 2009). Certain algae have 
long been used in traditional Chinese herbal medicine in 
the treatment of cancer (Yamamoto et al., 1984). Many 
studies have been developed in order to determine the 
bioactive compounds produced by marine algae (Albano 
et al., 1990; Berlinck et al., 1996). The activity against 
cancer cell lines is one of the most important specificities 
of marine algae, and many algae have showed cytotoxic 
and antitumor activities. Some metabolites such as 
bromophenols, carotene and steroids were isolated and 
purified in some algae and their activity against some 
cancer cell lines were demonstrated (Xu et al., 2004). 
Also, in another study, it was shown that the sulfated 
compounds such as fucoidans which were extracted from 
Sargassum polycystum and some other brown algae 
exhibited important roles against some human cancer cell 
lines (Ly et al., 2005). 
In this study, the water crude extract of G. corticata was 
studied for its probable antitumor activity against Jurkat 
and molt-4 cell lines which are two kinds of human leukemic 
cell lines. Based on previous experience, filtration method 
is the best way for algal extract sterilization (Zandi et al., 
2007). The heat sensitivity of some biological consti-
tuents of algal extract is the most important reason for not 
using autoclave for sterilizing extract. In this study, the 
cold water extract of G. corticata showed reasonable 
activity against tumor cells replication. The most effective 
concentration against Jurkat and molt-4 cells were 9.336 
and 9.726 µg/µl, respectively. As it is shown in Table 2, 
we can  conclude  that  the  algal  extract  did  not  exhibit  
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Table 3. The results of MTT assay test on Jurkat and molt-4 cell lines after treatment (72 h) with different 
concentration of G. corticata extract. 
 
OD at 540nm (molt-4 cells) OD at 540 nm (Jurkat Cells) Concentration of alga extract (µg/µl) 
0.810 0.911 0 
0.444 0.449 2.723 
0.390 0.429 4.668 
0.370 0.418 5.057 
0.326 0.333 5.835 
0.325 0.286 6.224 
0.315 0.284 7.391 
0.309 0.279 8.167 
0.290 0.264 8.947 
0.290 0.260 9.336 
0.255 0.260 9.726 
 
 
 
considerable cytotoxic effect against molt-4 cells. 
Meanwhile, its cytostatic effect was demonstrated. The 
number of dead cells related to Jurkat cells (Table 1) is 
higher than molt-4 cells (Table 2). The result of MTT 
assay for both cell lines is concordant with the data of 
performed viability tests for them (Table 3). In this study, 
the effective concentration is higher than other similar 
studies in which the purified biological active compound(s) 
were used instead of crude extract. Therefore, frac-
tionation and purification for G. corticata extract in future 
studies is recommended. Also, in regards to the significant 
results of this study, further investigations such as 
evaluation of in vivo anticancer activity of G. corticata is 
recommended and may lead to finding new effective 
natural antitumor compound(s). The red marine alga, G. 
corticata is an interesting alga because of its anticancer 
activity against human leukemic cell lines. Therefore, 
more studies for final application of this alga could be 
important in the field of natural antitumor investigation. 
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